Drug Shortage Report for EPINEPHRINE INJECTION USP

Last updated on 2025-02-01 History
Report ID 246001
Drug Identification Number 00721891
Brand name EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHINE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 X 1ML
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-19
Estimated end date
Actual end date 2025-01-31
Shortage status Resolved
Updated date 2025-02-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-02-01 English Compare
v5 2025-01-31 French Compare
v4 2025-01-31 English Compare
v3 2024-12-20 English Compare
v2 2024-12-19 French Compare
v1 2024-12-19 English Compare

Showing 1 to 6 of 6